´óÏóÊÓƵ

This fact sheet describes awards made by the ´óÏóÊÓƵ (AHRQ) in Fiscal Year (FY) 2010 to support trainees who are focusing on comparative effectiveness research. Funding to support these projects was provided through the American Recovery and Reinvestment of 2009.

Select to download print version (PDF, 268 KB).

Contents

Introduction
Comparative Effectiveness Research
American Recovery and Reinvestment Act
Programs
More Information

Introduction

The mission of the ´óÏóÊÓƵ (AHRQ) is to improve the safety, quality, efficiency, and effectiveness of health care for all Americans. To help achieve the Agency's mission, ´óÏóÊÓƵsupports extramural research grants and contracts, research training, conference grants, and intramural research activities. ´óÏóÊÓƵis committed to fostering the next generation of health services researchers who will focus their time and expertise on some of the most important problems facing our Nation's health care system.

This fact sheet describes awards made by ´óÏóÊÓƵin FY 2010 to support trainees who are focusing on comparative effectiveness research. Funding to support these projects was provided through the American Recovery and Reinvestment of 2009.

Return to Contents

Comparative Effectiveness Research

´óÏóÊÓƵhas been involved in comparative effectiveness research for many years. Since 2005, this work has been coordinated and supported through the Agency's Effective Health Care Program, which was authorized under Section 1013 of the Medicare Prescription Drug, Improvement, and Modernization Act of 2003.

Comparative effectiveness research—now also called patient-centered health research—compares the benefits and harms of different interventions and strategies to prevent, diagnose, treat, and monitor health conditions in "real world" settings. The purpose of this research is to improve health outcomes by developing and disseminating evidence-based information to patients, clinicians, and other decisionmakers about which interventions are most effective for which patients under specific circumstances. The Effective Health Care Program provides systematic reviews, supports new research to fill information gaps, and develops other translational information and tools designed to inform health care decisionmaking.

Return to Contents

American Recovery and Reinvestment Act

In FY 2009, ´óÏóÊÓƵreceived funds through the Recovery Act to build on its existing collaborative Effective Health Care Program. In response to the Recovery Act and recognizing the importance of enhancing research capacity and infrastructure, ´óÏóÊÓƵwill support two types of institutional research training and career development grants in FY 2010. These projects will focus on preparing new investigators to conduct comparative effectiveness research. Support will be provided to individuals who have clinical or research doctoral degrees and are focusing their research on the development and translation of new scientific evidence and analytic tools. In particular, the emphasis of these projects will be on developing and enhancing research and methodological capacities for carrying out comparative effectiveness research, integrating evidence into practice, and facilitating decisionmaking in the health care system.

Return to Contents

Programs

The Mentored Clinical Scientists Comparative Effectiveness Development Program (K12). This program provides support to institutions for the development of health services and clinical researchers who have made a commitment to focus their research on the translation and dissemination of new scientific evidence and analytical tools in comparative effectiveness. These awards will provide 3 years of supervised study and research for one cohort of individuals who have clinical and research doctoral degrees. The program provides salary support for an intensive, mentored research career development experience. Seven institutions received awards:

• University of Alabama at Birmingham; Kenneth Saag, MD, Principal Investigator; ´óÏóÊÓƵgrant K12 HS019465.
• University of Colorado, Denver; Anne Libby, PhD, Principal Investigator; ´óÏóÊÓƵgrant K12 HS019464.
• Duke University; Eugene Oddone, MD, Principal Investigator; ´óÏóÊÓƵgrant K12 HS019479.
• New York University School of Medicine; Ronald S. Braithwaite, MD, Principal Investigator; ´óÏóÊÓƵgrant K12 HS019473.
• University of North Carolina at Chapel Hill; Morris Weinberger, PhD, Principal Investigator; ´óÏóÊÓƵgrant K12 HS019468.
• Oregon Health and Science University; Jeanne-Marie Guise, MD, MPH, Principal Investigator; ´óÏóÊÓƵgrant K12 HS019456.
• University of Pittsburgh; Wishwa Kapoor, MD, Principal Investigator; ´óÏóÊÓƵgrant K12 HS019461.
• University of Washington; Sean Sullivan, PhD, Principal Investigator; ´óÏóÊÓƵgrant K12 HS019482.

Institutional National Research Service Award (NRSA) Postdoctoral Comparative Effectiveness Development Training Program (T32). In 2008, ´óÏóÊÓƵmade awards to 28 U.S. academic institutions through the National Research Service Award (NRSA) program to support advanced training to students with a strong interest in research careers. These institutions were given a competitive opportunity to expand these already established activities to support the postdoctoral training of health services and clinical researchers who have made a commitment to focus their research in comparative effectiveness. These awards will provide 2 years of supervised study for two cohorts of individuals with clinical and research doctoral degrees. The program will combine a mix of didactic, career development, mentoring, and hands-on research experiences. Six institutions received these awards:

• University of Alabama at Birmingham; Kenneth Saag, MD, Principal Investigator; ´óÏóÊÓƵgrant T32 HS019463.
• Brown University; Vincent Mor, PhD, Principal Investigator; ´óÏóÊÓƵgrant T32 HS019657.
• Children's Hospital, Boston; Jonathan Finkelstein, MD, Principal Investigator; ´óÏóÊÓƵgrant T32 HS019485.
• Duke University; David Edelman, MD, Principal Investigator; ´óÏóÊÓƵgrant T32 HS019490.
• Johns Hopkins University; Anne Duggan, ScD, Principal Investigator; ´óÏóÊÓƵgrant T32 HS019488.
• University of North Carolina at Chapel Hill; Timothy Carey, PhD, Principal Investigator; ´óÏóÊÓƵgrant T32 HS019442.
• University of Pittsburgh; Kevin Kraemer, MD, Principal Investigator; ´óÏóÊÓƵgrant T32 HS019486.

Return to Contents

More Information

For more information about the ´óÏóÊÓƵ, please visit the ´óÏóÊÓƵwebsite or go to AHRQ's .

Please select for more detailed information about the various training and career development programs supported by AHRQ.

For specific programmatic information, please contact:

Shelley Benjamin, MSW
Health Scientist Administrator
´óÏóÊÓƵ
5600 Fishers Lane
Rockville, MD 20857
301-427-1528
Shelley.Benjamin@ahrq.hhs.gov

Return to Contents